- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03454594
Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease
February 5, 2019 updated by: Ebtesam Nabil, Cairo University
Laser Hemotherapy Trial for Coronary Artery Disease Prevention in High Risk Patients
This study will evaluate the effect of low level laser blood radiation applied to all participants for prevention of coronary artery disease in patients with high risk (hypertension,high blood viscosity, hypercholesterolemia as well as related immune issues)
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The areas of low - intensity laser use have expanded in several conditions by different mechanisms and ways.
Hypertension as one of coronary artery disease risk factors and early indicator of future cardiovascular events with high blood viscosity and elevated blood cholesterol levels with immune-pathological basis became necessary issue to be handled.
Low Level Laser irradiation effects on blood is very essential way in revealing the mechanisms of the action of laser radiation on biological tissues by means of changes in metabolism, leading to molecular, cellular and systemic changes.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dokki
-
Giza, Dokki, Egypt, 11432
- Cairo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
53 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- stage I hypertensive patients
- patients from 30 to 34.9 kg/m2 body mass index
- medically stable patients
- all participants have sufficient cognition enough to understand the requirements of the study
Exclusion Criteria:
- history of malignant disease
- smoking
- history of progressive fatal disease
- history of drug or alcohol abuse
- blood donation within at least 30 days
- pregnant, trying to be pregnant or breast feeding
- cognitive impairment that will make it difficult to partake in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low level laser hemotherapy
Watch laser acupuncture and nasal irradiation
|
semiconductor laser therapeutic instrument irradiate the circulating blood in the vessels of left hand acupoint and the mucosal tissue in the nasal cavity
Other Names:
|
No Intervention: control
all the participants in this group did not receive low level laser irradiation during the study period
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes of blood pressure
Time Frame: 8 weeks
|
measuring blood pressure before and after each low level laser radiation
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes in blood viscosity
Time Frame: 8 weeks
|
measuring changes in blood viscosity before and after low level laser radiation session
|
8 weeks
|
change in IL-17 level
Time Frame: 45 days
|
measuring changes in IL-17 level before and after low level laser radiation session
|
45 days
|
change in functional capacity
Time Frame: 70 days
|
measuring of 6 minute walking test before and after low level laser irradiation as an indicator of functional capacity improving
|
70 days
|
change in CD 8 (cluster of differentiation 8) level
Time Frame: 45 days
|
measuring changes in CD 8 (cluster of differentiation 8) level before and after low level laser radiation session
|
45 days
|
change in TC (total cholesterol) level
Time Frame: 60 days
|
measuring changes in TC (total cholesterol) level before and after low level laser radiation session
|
60 days
|
change in LDL (low density lipoprotien) level
Time Frame: 60 days
|
measuring changes in LDL (low density lipoprotien) level before and after low level laser radiation session
|
60 days
|
change in TG (triglyceride) level
Time Frame: 60 days
|
measuring changes in TG (triglyceride) level before and after low level laser radiation session
|
60 days
|
change in HDL (high density lipoprotien) level
Time Frame: 60 days
|
measuring changes in HDL (high density lipoprotien) level before and after low level laser radiation session
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cairo Giza, MD, Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
August 5, 2018
Study Completion (Actual)
December 30, 2018
Study Registration Dates
First Submitted
February 25, 2018
First Submitted That Met QC Criteria
March 3, 2018
First Posted (Actual)
March 6, 2018
Study Record Updates
Last Update Posted (Actual)
February 7, 2019
Last Update Submitted That Met QC Criteria
February 5, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/001561
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
De-identified participated data for underlie results reported in this trial
IPD Sharing Time Frame
data will be available after 6 months of study completion and ending 36 months
IPD Sharing Access Criteria
proposals should directed to Dr.EbtesamNagy@cu.edu.eg.
To gain access, data requestors will need to sign a data access agreement
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on low level laser hemotherapy
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
University of Texas Southwestern Medical CenterTerminatedChronic PainUnited States
-
University of Nove de JulhoSimone Aparecida Penimpedo Calamita; Fabiana Sarilho de Mendonça; Daniela Aparecida... and other collaboratorsCompleted
-
University of BergenCompleted
-
University of BergenNorwegian Fund for Postgraduate Training in PhysiotherapyCompleted
-
Legacy Health SystemCompletedPeripheral NeuropathyUnited States
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
Tehran University of Medical SciencesCompletedGingival RecessionIran, Islamic Republic of
-
St. Elisabethen Krankenhaus Frankfurt GmbHRecruitingSurgical Scar Tissue of Cesarean Section or Vaginal Tear or EpisiotomyGermany
-
Institut Cancerologie de l'OuestUnknownOral Mucositis | Oral Squamous Cell Carcinoma | Squamous Cell Carcinoma of Hypopharynx | Squamous Cell Carcinoma of OropharynxFrance